Kevin McLaughlin

3 weeks ago | cancertodaymag.org | Kevin McLaughlin

ALFRED LACKS CARTER JR. is on a mission to foster “health intelligence” in communities of color. Carter comes from a family where the importance of understanding your health care has a special resonance: His grandmother was Henrietta Lacks, a cervical cancer patient whose cells were harvested and cultured without her knowledge. Lacks’ cells, called HeLa cells after the first two letters of her first and last names, are still used in medical research.

4 weeks ago | cancertodaymag.org | Kevin McLaughlin

Every week, the editors of Cancer Today magazine bring you the top news for cancer patients from around the internet. Stay up to date with the latest in cancer research and care by subscribing to our e-newsletter. A single dose of a human papillomavirus (HPV) vaccine provides similar protection from the disease as two doses, according to results of the ESCUDDO trial presented at the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago.

1 month ago | cancertodaymag.org | Kevin McLaughlin

BREAST CANCER DEATH RATES declined dramatically between 2010 and 2020 for U.S. women ages 20 to 49, according to a study presented at the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago. (The AACR publishes Cancer Today.)Using breast cancer data from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) program, researchers analyzed 11,661 breast cancer deaths in the decade between 2010 and 2020.

1 month ago | cancertodaymag.org | Kevin McLaughlin

ON A DAY when thousands of cancer researchers held up placards reading “Cancer Research Saves Lives” at the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago, researchers, former directors of federal agencies and cancer survivors discussed the crisis in federal support for research. (The AACR publishes Cancer Today.)Delays and halts in federal funds and staff layoffs at federal agencies put cancer research and future treatment breakthroughs at risk, said Patricia M.

1 month ago | cancertodaymag.org | Kevin McLaughlin

Every week, the editors of Cancer Today magazine bring you the top news for cancer patients from around the internet. Stay up to date with the latest in cancer research and care by subscribing to our e-newsletter. Testing for an experimental cell-based immune therapy that shows promise in treating gastrointestinal cancer has been delayed by layoffs among highly trained staff at the National Institutes of Health (NIH). Steven A.